Gladstone Labs and Nrf2 Protein
https://gladstone.org/about-us/news/single-protein-may-hold-secret-treating-parkinson-s-disease-and-more

Read Joan Beal's recent blog entry: http://ccsviinms.blogspot.com/2017/02/gladstone-labs-and-nrf2-protein.html?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+MultipleSclerosis--theVascularConnection+%28Multiple+Sclerosis--the+vascular+connection%29

Quoted from Gladstone Labs: "The scientists say that Nrf2 itself may be difficult to target with a drug because it is involved in so many cellular processes, so they are now focusing on some of its downstream effects. They hope to identify other players in the protein regulation pathway that interact with Nrf2 to improve cell health and that may be easier to drug."

Alliance comment: Dr. Joe McCord - Univ of Colorado "Superoxide dismutase, better known as SOD, is an important antioxidant defense in nearly all cells exposed to oxygen. Dr. McCord discovered this enzyme in 1969. SOD is turned on by Nrf2 and is made by most cells to detoxify superoxide, a compound that the immune system deploys to destroy invading microorganisms. Dr McCord developed a natural supplement to activate Nrf2 -- do we really need a drug?

New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson’s, Huntington’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS).